PROM1 and liver cancer: Consistent with the findings from fluorescence-based studies (Figure 3), the intracellular concentration of DOX delivery by CD133 aptamer-DOX conjugates in the bulk and sphere-forming liver cancer cells was found to be several folds higher than that in cells treated with an equivalent concentration of free DOX (p < 0.01) (Supplementary Figures S5 and S6).